All about the fund UBS Lux Equity Fund Biotech USD P-acc, which stocks or funds the fund owns, and how much the fund owns of each holding.
Details
Security
UBS Lux Equity Fund Biotech USD P-acc
Fee
2,25%
ISIN
LU0069152568
Currency
USD
Holdings
9
Recent performance of UBS Lux Equity Fund Biotech USD:
| 1M | 1.69% |
| 3M | -11.17% |
| YTD | -6.38% |
Find funds with similar holdings as UBS Lux Equity Fund Biotech USD here:
| Security | Fee | ||
|---|---|---|---|
1 |
SEB Bioteknikfond D EUR Lux Utd The fund's holdings match to 67% The fund's fee of 1,69% is 0,56 lower Annual Dividend |
(i) | |
| 2 |
Avanza Healthcare by Samuelsson & Hult The fund's holdings match to 56% The fund's fee of 1,25% is 1 lower |
(i) | |
The fund UBS Lux Equity Fund Biotech USD P-acc has 11 holdings, with the largest being Regeneron Pharmaceuticals at 10.04%, followed by Moderna at 9.21% and Vertex at 8.44%.
Here are all holdings in UBS Lux Equity Fund Biotech USD:
| # | Security | Share | ||
|---|---|---|---|---|
| 1 | US75886F1075 |
(i) | ||
| 2 | US60770K1079 |
(i) | ||
| 3 | US92532F1003 |
(i) | ||
| 4 | US02043Q1076 |
(i) | ||
| 5 |  |
US00287Y1091 |
(i) | |
| 6 | |
US3755581036 |
(i) | |
| 7 | |
US0311621009 |
(i) | |
| 8 | US09075V1026 |
(i) | ||
| 9 | US48576A1007 |
(i) | ||
14% of the fund's holdings are from USA.
| AbbVie Inc 4.91% |
| Amgen Inc 4.43% |
| Gilead Sciences Inc 4.66% |
The list of fund holdings was last updated on July 20, 2025.
Compare UBS Lux Equity Fund Biotech USD P-acc with other funds to see how the allocation differs.
